References
- Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm (Vienna). 2017;124(8):901–905.
- Schneider RB, Iourinets J, Richard IH. Parkinson’s disease psychosis: presentation, diagnosis and management. Neurodegener Dis Manag. 2017;7(6):365–376.
- Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–1272.
- Reich SG, Savitt JM. Parkinson’s disease. Med Clin North Am. 2019;103(2):337–350.
- Wang B, Abraham N, Gao G, et al. Dysregulation of autophagy and mitochondrial function in Parkinson’s disease. Transl Neurodegener. 2016;5:19.
- Hou X, Watzlawik JO, Fiesel FC, et al. Autophagy in Parkinson’s disease. J Mol Biol. 2020;432(8):2651–2672.
- Towers CG, Thorburn A. Therapeutic targeting of autophagy. EBioMedicine. 2016;14:15–23.
- Wu AG, Wong VK, Xu SW, et al. Onjisaponin B derived from radix polygalae enhances autophagy and accelerates the degradation of mutant α-synuclein and huntingtin in PC-12 cells. Int J Mol Sci. 2013;14(11):22618–22641.
- Lin TK, Chen SD, Chuang YC, et al. Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy. Int J Mol Sci. 2014;15(1):1625–1646.
- Zhao XX, Peng C, Zhang H, et al. Sinomenium acutum: a review of chemistry, pharmacology, pharmacokinetics, and clinical use. Pharm Biol. 2012;50(8):1053–1061.
- Cheng JJ, Tsai TH, Lin LC. New alkaloids and cytotoxic principles from sinomenium acutum. Planta Med. 2012;78(17):1873–1877.
- Gao T, Hao J, Wiesenfeld-Hallin Z, et al. Analgesic effect of sinomenine in rodents after inflammation and nerve injury. Eur J Pharmacol. 2013;721(1–3):5–11.
- Gao T, Shi T, Wiesenfeld-Hallin Z, et al. Sinomenine facilitates the efficacy of gabapentin or ligustrazine hydrochloride in animal models of neuropathic pain. Eur J Pharmacol. 2019;854:101–108.
- Qian L, Xu Z, Zhang W, et al. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflamm. 2007;4:23.
- Gao Z, Lin Y, Zhang P, et al. Sinomenine ameliorates intervertebral disc degeneration via inhibition of apoptosis and autophagy in vitro and in vivo. Am J Transl Res. 2019;11(9):5956–5966.
- Miao Y, Guo D, Li W, et al. Diabetes promotes development of Alzheimer’s disease through suppression of autophagy. J Alzheimers Dis. 2019;69(1):289–296. PubMed PMID: 30958383; eng.
- Rui W, Li S, Xiao H, et al. Baicalein attenuates neuroinflammation by inhibiting NLRP3/caspase-1/GSDMD pathway in MPTP induced mice model of Parkinson’s disease. Int J Neuropsychopharmacol. 2020;23(11):762–773. doi: 10.1093/ijnp/pyaa060.
- Qiu J, Wang M, Zhang J, et al. The neuroprotection of sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling. Int Immunopharmacol. 2016;40:492–500.
- Zhou J, Yao W, Li C, et al. Administration of follicle-stimulating hormone induces autophagy via upregulation of HIF-1α in mouse granulosa cells. Cell Death Dis. 2017;8(8):e3001.
- Lee YR, Wang PS, Wang JR, et al. Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model. J Biomed Sci. 2014;21(1):80.
- Singh B, Pandey S, Yadav SK, et al. Role of ethanolic extract of Bacopa monnieri against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced mice model via inhibition of apoptotic pathways of dopaminergic neurons. Brain Res Bull. 2017;135:120–128.
- Haelterman NA, Yoon WH, Sandoval H, et al. A mitocentric view of Parkinson’s disease. Annu Rev Neurosci. 2014;37:137–159.
- Langston JW. The MPTP story. J Parkinsons Dis. 2017;7(s1):S11–s19.
- Mustapha M, Mat Taib CN. MPTP-induced mouse model of Parkinson’s disease: a promising direction of therapeutic strategies. Bosn J Basic Med Sci. 2021;21(4):422–433.
- Nagatsu T, Nakashima A, Ichinose H, et al. Human tyrosine hydroxylase in Parkinson’s disease and in related disorders. J Neural Transm (Vienna). 2019;126(4):397–409.
- Nagar R. Autophagy: a brief overview in perspective of dermatology. Ind J Dermatol Venereol Leprol. 2017;83(3):290–297.
- Bednarczyk M, Zmarzły N, Grabarek B, et al. Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis. Oncotarget. 2018;9(76):34413–34428.
- Xu HD, Qin ZH. Beclin 1, Bcl-2 and autophagy. Adv Exp Med Biol. 2019;1206:109–126.
- Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol. 2008;445:77–88.
- Liu H, Dai C, Fan Y, et al. From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases. J Bioenerg Biomembr. 2017;49(5):413–422.
- Xu Z, Han X, Ou D, et al. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol. 2020;104(2):575–587.
- Jin SY, Lee HS, Kim EK, et al. Reactive oxygen species and PI3K/Akt signaling in cancer. Free Radic Biol Med. 2014;75(Suppl 1):S34–S5.
- Rodon J, Dienstmann R, Serra V, et al. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol. 2013;10(3):143–153.
- Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015;125(1):25–32.
- Sun Z, Zheng L, Liu X, et al. Sinomenine inhibits the growth of melanoma by enhancement of autophagy via PI3K/AKT/mTOR inhibition. Drug Des Devel Ther. 2018;12:2413–2421.